Jiangsu Nhwa Pharmaceutical Co Ltd SZSE:002262:
SAYS Q3 NET PROFIT UP 3.7% Y/Y
Jiangsu Nhwa Pharmaceutical Q3 Net Profit Up 3.7% Y/Y
Earlier from Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A
- Jiangsu Nhwa Pharmaceutical: Net profit up 11.38% year-over-year, with strong CNS drug sales and R&D growth
- Jiangsu Nhwa Pharmaceutical: Q1 2025 net profit up 13.35% year-over-year on strong sales and investment returns
- Jiangsu Nhwa Pharmaceutical: 2024 revenue and net profit rose double digits, with strong CNS drug and digital health growth
- Jiangsu Nhwa Pharmaceutical: Q3 2024 saw double-digit revenue and profit growth, with robust cash flow and rising EPS